Blog

Sweet Deception: How a New Antibody Therapy Unmasks Pancreatic Cancer Sweet Deception: How a New Antibody Therapy Unmasks Pancreatic Cancer Pancreatic cancer remains one of the most formidable challenges in oncology, with a grim 5-year survival rate of just 13%. Its resistance to even the most advanced immunotherapies has long puzzled scientists. Now, a groundbreaking study from Northwestern Medicine has uncovered a key reason why: pancreatic tumors cloak themselves in a sugar-based disguise to evade the immune system. [1] Introduction to Glyco-Immunology The study, published in Cancer Research, delves into the emerging field of g …